Eli Lilly is partnering with Hims & Hers to sell its weight loss drugs
Summary
The agreement covers Zepbound and Foundayo for patients who pay out of pocket through the telehealth platform
Description from Quartz.
Who is covering this
-
Eli Lilly is partnering with Hims & Hers to sell its weight loss drugs
The agreement covers Zepbound and Foundayo for patients who pay out of pocket through the telehealth platform
-
Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth... Reuters Health Information
Related stories
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump
2 sourcesvia ReutersTruth score 551
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
1 sourcevia Google NewsTruth score 41
Doctors in England launch primary-care trial of blood tests for spotting cancer early
2 sourcesvia ReutersTruth score 52
US hospitals brace for tougher 2027 as coverage losses and Medicaid cuts loom
2 sourcesvia Times of IndiaTruth score 48
Albertsons Must Pay $900 Million for Fueling Opioid Epidemic in Washington State, Judge Rules
1 sourcevia MedscapeTruth score 38
Yemen war: Pregnant women struggle to access life-saving healthcare
3 sourcesvia Al Jazeera EnglishTruth score 571
Comments
Comments need JavaScript.